A Novel Data-Driven Framework for Risk Characterization and Prediction
  from Electronic Medical Records: A Case Study of Renal Failure by Chakraborty, Prithwish et al.
A Novel Data-Driven Framework for Risk Characterization
and Prediction from Electronic Medical Records: A Case
Study of Renal Failure
Prithwish Chakraborty∗1, Vishrawas Gopalakrishnan†1, Sharon M.H.
Alford‡3, and Faisal Farooq§4
1IBM Watson Health, MA, USA
2IBM Watson Health, MI, USA
3IBM Watson Health, NY, USA
Abstract
Electronic medical records (EMR) contain longitudinal information
about patients that can be used to analyze outcomes. Typically, studies
on EMR data have worked with established variables that have already
been acknowledged to be associated with certain outcomes. However,
EMR data may also contain hitherto unrecognized factors for risk
association and prediction of outcomes for a disease. In this paper, we
present a scalable data-driven framework to analyze EMR data corpus in
a disease agnostic way that systematically uncovers important factors
influencing outcomes in patients, as supported by data and without
expert guidance. We validate the importance of such factors by using
the framework to predict for the relevant outcomes. Specifically, we
analyze EMR data covering approximately 47 million unique patients to
characterize renal failure (RF) among type 2 diabetic (T2DM) patients.
We propose a specialized L1 regularized Cox Proportional Hazards
(CoxPH) survival model to identify the important factors from those
available from patient encounter history. To validate the identified
factors, we use a specialized generalized linear model (GLM) to predict
the probability of renal failure for individual patients within a specified
time window. Our experiments indicate that the factors identified
via our data-driven method overlap with the patient characteristics
recognized by experts. Our approach allows for scalable, repeatable and
efficient utilization of data available in EMRs, confirms prior medical
knowledge and can generate new hypothesis without expert supervision.
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Introduction
The growth and wide-spread adoption of Electronic Medical Record (EMR)
systems [1, 2, 3] has led to efficient recording of patient characteristics and
their encounter details that makes the information accessible for secondary
data purposes. The resultant rich longitudinal view of the patients’ disease
progression and treatment response, allows for novel analyses, even leading
to revision of the recommended treatment and patient-care plans [4, 5, 6].
Machine learning approaches furthermore provide robust methods to harvest
and compute large data stores, alleviating past limitations of epidemiological
studies on clinical data [7]. Increased adoption of EMR standards and health
information exchanges, primarily by online and cloud-based data marts [8],
have further led to efficient linking of patient encounters/visits across hospitals
and addresses many of the concomitant issues with using EMR data such
as missing information and temporal blind-spots. Consequently, data driven
clinical studies are now feasible and coupled with large EMR datasets can
now, for the first time, lead to discovery of hitherto unknown associations
between complex chronic diseases.
In this work, we focus on a disease agnostic data-driven approach to
identify novel factors associated with disease characterization as supported
by data and without necessitating expert guidance. Our framework is de-
signed to be scalable and modifies the classic epidemiological survival model,
Cox proportional hazard model [9]. The modifications allow us to identify
relevant attributes and validate the same via outcome prediction automati-
cally. Specifically, we exploit the relationship between survival model and
Generalized Linear Model(GLM) [10] to create a L1 regularized proportional
hazard model for characterization backed by a L1 regularized GLM regression
model to predict the occurrence of adverse or critical events. This approach
provides the flexibility to overcome the traditional limitation of survival
models, specifically the tracking of the disease/event progression only up to
the maximum duration present in the training set. At the same time, survival
models provide a principled approach to handle “right censored” data points
that is data is truncated at the time of last follow-up without knowing if
the patient eventually developed the outcome of interest. Compared to prior
studies [7] our model by virtue of its data-driven regularization can identify
factors that are significant as supported by the EMR instead of relying only
on expert knowledge. Newly revealed factors can then be verified from out-
come prediction and be added to the list of early warning indicators to be
monitored. To illustrate our framework, we provide a use-case characterizing
renal failure (RF) in Type 2 Diabetes Mellitus (T2DM). To summarize, our
key contributions are:
• We present a scalable L1 regularized proportional hazard model to discover
information from EMR about factors that can influence outcomes in
patients, without expert guidance.
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• We present a GLM regression model to predict the occurrence of events
amongst patients using factors discovered via survival modeling while
adhering to the underlying generative process.
Methods
Experimental Setup: We use a de-identified EMR corpus of approximately
47 million unique patients covering 1.6 billion medical encounters. We
construct a type 2 diabetic cohort spanning the time period 1990-2016 and
covering 4 million patients, following a three step definition: (a) patients must
have been diagnosed with type 2 diabetes anytime within this period (presence
of snomed concepts), (b) they must have had abnormal HbA1C levels (HbA1C
≥ 5.7) from lab observations corresponding to such diagnosis, and (c) had at
least 3 diabetes related encounters within this period. A patient satisfying all
the three criteria is considered to be diabetic and included in the cohort and,
the first time-point when these criteria are satisfied is considered to be the
first diagnosis date for the patient. This definition ensures that patients have
been identified as diabetic from both procedural and diagnostic methods,
thus reducing false positives. From the EMR records, we create normalized
medical histories of patients by resolving observations and outcomes with
encounters. Furthermore, we admit both positive and negative cases of renal
failure (acute and chronic).
Feature Identification: Typically, experts look at a fixed set of factors
such as age, weight and HbA1c level in blood while analyzing renal failures
in diabetic patients. In this study, we aim to identify other possible indi-
cators, as supported by the data, from the corpus of near-complete patient
medical histories. Following classical bio-statistical approaches, risk factors
for extreme outcomes like renal failure can be characterized using survival
models such as Cox Proportional Hazard (CoxPH) models [9]. In these
models, conditional event rates or hazards (λ(t)) associated with factors
Xi = {Xi,1, . . . , Xi,p} characterizes the corresponding risk of outcomes which,
for a patient i, can be given as:
λ(t|Xi) = λ0(t) exp(β1Xi1 + · · ·+ βpXip) = λ0(t) exp(Xi · β)
where, λ0(t) denotes the baseline hazard at time t (independent of patient
covariates) and βj denotes the regression weight of the factor j. To identify
and characterize such factors from the data, we use L1 regularized survival
models which have been proven to be effective in other domains [11]. Specifi-
cally, we find these parameters by fitting the regularized log-likelihood ratio
(eq. 1) against normalized EMR history of the patients in the cohort.
`(β) =
∑
j
(
∑
i∈Hj
Xi · β −
m−1∑
`=0
log(
∑
i:Yi≥tj
θi − `
m
∑
i∈Hj
θi)) + γ‖β‖1 (1)
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Table 1: Top data-driven factors for renal failure in T2DM patients as
extracted from EMR.
LOINC description coef. value
8277-6 Body surface Area 1.536450e-01
28542-9 Platelet mean volume 2.762536e-02
30180-4 Basophils/100 leukocytes 2.447092e-02
ET3111-5 1.967411e-02
6299-2 Urea Nitrogen 1.112565e-02
26450-7 Eosinophils/100 leukocytes 8.770401e-03
3094-0 Urea nitrogen [Mass/volume] 3.679680e-03
ET3123-9 3.000471e-03
26511-6 Neutrophils/100 leukocytes 2.930090e-03
26444-0 Basophils [#/volume] in Blood 1.513770e-03
2345-7 Glucose 5.521050e-04
26484-6 Monocytes 4.750066e-04
8480-6 Intravascular systolic 2.682153e-04
2339-0 Glucose [Mass/volume] in blood 1.919959e-04
2571-8 Triglyceride 1.305691e-04
8310-5 Body temperature 1.291046e-04
1920-8 Aspartate aminotransferase 1.268876e-04
1742-6 Alanine aminotransferase 1.218098e-04
26499-4 Neutrophils 2.527398e-05
14957-5 Albumin 8.445566e-07
8867-4 Heart Rate 9.496403e-13
where, γ is the L1 penalty factor and we identify the factors which are (a)
statistically significant for survival outcomes and (b) associated with the
largest regression weights (β(> 0)).
Renal Failure Prediction: We validate the data-driven factors by using
these as covariates to predict for renal failure in type 2 diabetic patients based
on their medical histories. Although survival models are not particularly
suited for prediction on time-intervals outside the training data, we note
that the partial log-likelihood in CoxPH models have close ties to logistic
GLM regressions [10]. We use a regularized logistic regression (eq. 2) to use
these factors to predict for the possibility of renal failure. We use the average
history of factors within a pre-defined observation period (first n ∈ {6,9,12}
months from first diagnosis date) in a rolling window setup and predict the
occurrence of renal failure in the prediction period (the next 3 months).
`logistic = min
w,d
‖w‖1 +D
∑
n
i=1 log(exp(−yi(XTi w + d)) + 1) (2)
Results
Table 1 tabulates the top statistically significant data-driven factors w.r.t.
survival as identified via eq. 1 from our T2DM patient corpus. Table 1 shows
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(a) Age (b) Gender (c) HbA1c
(d) Race (e) Weight (f) LOINC 8227-6
Figure 1: Adjusted baseline survival ratio with respect to individual factors
that our method uncovers several observational attributes, from the data
and without expert input, that are potentially correlated with an increased
risk of renal failures. We validate the importance of these factors using
our predictive model as shown in Table 2 which shows that the outcome
prediction performance increases when expert factors are supplemented by
data-driven factors - thus indicating that the data-driven factors may be
uncovering hidden correlations and thus, of potential interest to experts.
Here, we found the L1 penalty using 5 fold cross validation and for each
observation period, we used 10 fold cross-validation to quantify accuracy,
sensitivity, and specificity.
Table 2: Comparison of outcome prediction performance for renal failure
amongst Type 2 Diabetic patients. Combination of data-driven and expert
factors exhibits the best overall performance.
Model attributes Accuracy Specificity Sensitivity
Only expert features 0.86 0.89 0.68
Data driven features 0.89 0.92 0.71
expert + data -driven features 0.91 0.93 0.73
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Discussion
In this section we briefly discuss some interesting findings from our assay.
Relative importance of factors : We ascertain the relative importance
of factors using coefficient rankings in Table 1, where the coefficients are
calculated in the presence of other factors. Following classical survival analysis
methodology, we further investigate the importance of each individual factor
using adjusted survival ratios. We create the adjusted ratio for a factor by
marginalizing against other factors, setting such factors to their mean or most
prevalent value (depending on the type of the factor). Figure 1 shows the
adjusted ratios for the most important data driven as well as Expert factors.
As can be seen when marginalized, we can uncover certain characteristics
within the factors. For example, males are generally at higher risk than
females. While weight and renal risk exhibits an inverse ratio, HbA1c shows
a direct ratio with renal failure risk. Interestingly, the difference is not as
marked in the case of LOINC 8277-6.
Are there any significant factors not identified by survival mod-
els : Although weight is one of the factors considered by experts, it ranks
low from our data-driven framework. We posit that this could indicate that
that effects identified by weight may already be covered by other factors and
hence its ranking is not significant. Interestingly, the importance of gender
and race remain constant throughout different models - indicating that these
are fundamental factors. A possible extension to analyze these factors in
depth could be a stratified approach. However, such approaches can obscure
the importance of the fundamental factors
How does the observation period affect the prediction perfor-
mance : Table 2 reports the overall prediction accuracy for our experimental
setup. However, the prediction performance when viewed as a function of
the observation period (see Figure 2), uncovers interesting patterns. It can
be seen that, in general, increasing the observation period increases the
prediction accuracy. It is to be noted, increasing the observation doesn’t
necessarily increase the amount of data observed in general (as we are taking
average history of patients who haven’t had a renal failure in the observation
period). One possible explanation could be the fact that with the increase in
observation period, more renal failures happen in the subsequent prediction
period and as such the prediction problem becomes less skewed and well-
defined. This indicates that while dealing with low observation periods we
may need to include additional strategies such as SMOTE [12].
Conclusion
In this paper, we propose a systematic framework for identifying risk factors
for outcomes as supported by data from EMR corpus. We showcase our
framework on renal failures for diabetic patients and discussed various com-
ponents of the same. Our experiments indicate that the framework is able to
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Figure 2: Prediction accuracy as a function of observation period
identify significant factors. However, certain factors as identified by experts
don’t rank highly from this framework. Further research is needed to model
hidden interactions between factors to distinguish between ‘fundamental’
factor and derivative factors.
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